GRTS down 38% on offering - The biotechnology company said the offering consists of 8.3 million shares and accompanying warrants to buy up to 8.3 million shares at a per share exercise price of $1.65.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.